Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA expands approval of Adcetris for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy

March 20, 2018Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

FDA approves Adcetris (brentuximab vedotin) to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma (cHL) in combination with chemotherapy

Post navigation

← Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to reduce tobacco use, especially among youth, by exploring options to address the role of flavors ‒ including menthol ‒ in tobacco products Radagast Pet Food, Inc. Voluntarily Recalls One Lot of Rad Cat Raw Diet Free-Range Chicken and One Lot of Free-Range Turkey Recipe Because of Possible Health Risk →
Proudly powered by WordPress